RA
EOLS icon

Royce & Associates’s Evolus EOLS Stock Holding History

Royce & Associates’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-128,000
Closed -$531K – 1179
2020
Q1 		$531K Hold
128,000
– – 0.01% 822
2019
Q4 		$1.56M Hold
128,000
– – 0.01% 739
2019
Q3 		$2M Hold
128,000
– – 0.02% 704
2019
Q2 		$1.87M Buy
128,000
+100,000
+357% +$1.98M 0.02% 737
2019
Q1 		$632K Buy
+28,000
New +$605K 0.01% 900

Other funds holding EOLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Royce & Associates's EOLS Position: Q2 2020 in Review

Royce & Associates sold out of Evolus (EOLS) in Q2 2020, closing a stake of 128,000 shares — an estimated $531K sold.

Royce & Associates first reported a position in EOLS in Q1 2019 and held it in 5 quarters. The position peaked at $2M in Q3 2019. 90 funds tracked by Wall St. Rank hold EOLS as of Q2 2020.

  • Royce & Associates reported no remaining Evolus position as of Q2 2020 after selling out during the quarter.
  • Royce & Associates sold 128,000 Evolus shares in Q2 2020, an estimated $531K.
  • Royce & Associates first reported a position in Evolus in Q1 2019 and held it in 5 quarters.
  • Royce & Associates's Evolus position peaked at $2M in Q3 2019.
  • 90 funds tracked by Wall St. Rank held Evolus as of Q2 2020.

Based on Royce & Associates's 13F filing for Q2 2020, filed 7 Aug 2020.